Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 3, 2000, Pages 559-566

  Hanlon, Alexandra L ^a   Hanks, Gerald E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Biochemical failure; Conformal; Prostate specific antigen; Radiation therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER PATIENT; CANCER REGISTRY; DISEASE MARKER; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS; TREATMENT FAILURE;

EID: 0033976171     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00450-2     Document Type: Article

References (12)

1. Killian C.S., Yang N., Emrich L.J., Vargas F.P., Kuriyama M., Wang M.C., Slack N.H., Papsidero L.D., Murphy G.P., Chu T.M. Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer. Cancer Res. 45:1985;886-891.
2. Oesterling J.E., Chan D.W., Epstein J.I., Kimball A.W., Bruzek D.J., Rock R.C., Brendler C.B., Walsh P.C. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol. 139:1988;766-772.
3. Partin A.W., Pound C.R., Pearson J.D., Clemens J.Q., Landis P.K., Epstein J.I., Carter H.B., Walsh P.C. Evaluation of serum prostate specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology. 43:1994;649-659.
4. Horwitz E., Vicini F., Ziaja E., Gonzalez J., Dmuchowski C., Stromberg J., Brabbins D., Hollander J., Chen P., Martinez A. Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control. Int J Radiat Oncol Biol Phys. 36:1996;565-571.
5. Consensus statement Guidelines for PSA following radiation therapy . Int J Radiat Oncol Biol Phys. 37:1997;1035-1041.
6. Slivjak A., Pinover W., Hanlon A., Horwitz E., Hanks G. The ASTRO consensus definition of bNED failure is an inappropriate endpoint for prostate cancer patients receiving conformal radiation therapy and androgen deprivation (CRT + AD). Int J Radiat Oncol Biol Phys. 42:1998;176.
7. Fleming I., Cooper J., Henson D., Hutter R., Kennedy B., Murphy G., O'Sullivan B., Sobin L., Yarbro J. AJCC cancer staging manual. 1997;Lippincott-Raven, Philadelphia, New York.
8. Hanks G.E., Lee W.R., Hanlon A.L., Hunt M., Kaplan E., Epstein B.E., Schultheiss T.E. Conformal technique dose escalation for prostate cancer biochemical evidence of improved cancer control with higher doses in patients with pretreatment PSA ≥ 10 ngm/ml . Int J Radiat Oncol Biol Phys. 35:1996;861-868.
9. Movsas B., Hanlon A., Teshima T., Hanks G. Analyzing predictive models following definitive radiotherapy for prostate carcinoma. Cancer. 80:1997;1093-1102.
10. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
11. Ennis R., Malyszko B., Heitjan D., Rubin M., O'Toole K., Schiff P. Changes in biochemical disease-free survival rates as a result of adoption of the consensus conference definition in patients with clinically localized prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys. 41:1998;511-517.
12. Horwitz E., Vicini F., Ziaja E., Dmuchowski C., Stromberg J., Martinez A. The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. Int J Radiat Oncol Biol Phys. 41:1998;267-272.